A new study from the University of Pennsylvania’s Perelman School of Medicine offers a nuanced view of how diabetes is ...
Hosted on MSN1mon
Diabetic eye disease up, but most severe forms down since 2014The incidence rate of one of the most severe forms of the disease, proliferative diabetic retinopathy, fell by almost 300% since 2002, going from 8.3 per 1,000 person-years to just 2.6 in 2022 ...
A new study reveals a troubling trend: nearly 10 million Americans are now living with diabetic retinopathy, a complication ...
He is studying methazolamide, a treatment currently used to manage glaucoma, to find out if it can also help treat ...
The SMART India Study conducted across multiple states and one union territory examined DR prevalence in over 6,000 people ...
The findings, published in JAMA Ophthalmology, show how “continuous delivery of anti-VEGF [vascular endothelial growth factor] can really benefit patients with diabetic eye disease,” Khanani ...
Clearside Biomedical (CLSD) announced that presentations on the Company’s lead clinical program, CLS-AX in neovascular age-related macular ...
Optimizing Clinical Trial Design & Navigating Regulatory Landscape for Wet AMD & Diabetic Eye Disease Therapies Presentation by: Victor Chong, MD, MBA, Clearside Biomedical Summary: This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback